Old Web
English
Sign In
Acemap
>
Paper
>
Bevacizumab as Anti-VEGF Therapy for Retinopathy of Prematurity: A Histopathologic Study
Bevacizumab as Anti-VEGF Therapy for Retinopathy of Prematurity: A Histopathologic Study
2008
Rebecca L. Penland
L. Kong
H. Mintz-Hittner
F. Kretzer
Patricia Chévez-Barrios
Keywords:
Gastroenterology
Diabetes mellitus
Bevacizumab
Histopathologic Study
VEGF receptors
Retinopathy of prematurity
Internal medicine
Anatomy
Biology
anti vegf
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]